Skip to main content
. 2023 Mar 9;5(5):100624. doi: 10.1016/j.xkme.2023.100624

Table 1.

Baseline Characteristics of Incident Chronic Kidney Disease Patients Based on Heart Failure Status (2007-2017)

Heart Failure
No HF Total
No EF EF > 40% EF ≤ 40%
N 2,485 8,436 3,328 62,439 76,688
Age at index date, mean (SD) 75.9 (11.04) 75.6 (11.31) 73.9 (11.22) 71.7 (12.36) 72.4 (12.24)
Sex, n (%)
 Male 1,242 (50.0%) 3,964 (47.0%) 2,166 (65.1%) 27,688 (44.3%) 35,060 (45.7%)
 Female 1,243 (50.0%) 4,472 (53.0%) 1,162 (34.9%) 34,751 (55.7%) 41,628 (54.3%)
Race/ethnicity, n (%)
 White 1,524 (61.3%) 4,751 (56.3%) 1,687 (50.7%) 31,879 (51.1%) 39,841 (52.0%)
 Asian 139 (5.6%) 576 (6.8%) 235 (7.1%) 5,832 (9.3%) 6,782 (8.8%)
 Black 289 (11.6%) 1,204 (14.3%) 610 (18.3%) 8,116 (13.0%) 10,219 (13.3%)
 Hispanic 411 (16.5%) 1,783 (21.1%) 736 (22.1%) 15,016 (24.0%) 17,946 (23.4%)
 Other/unknown 122 (4.9%) 122 (1.5%) 60 (1.8%) 1,596 (2.6%) 1,900 (2.5%)
BMI, kg/m2
 Mean (SD) 30.1 (7.72) 30.3 (7.68) 28.1 (6.28) 29.2 (6.66) 29.3 (6.81)
 < 18.5 26 (1.1%) 147 (1.7%) 57 (1.7%) 900 (1.4%) 1,130 (1.5%)
 18.5-24.9 463 (18.6%) 1,723 (20.4%) 942 (28.3%) 13,111 (21.0%) 16,239 (21.2%)
 25-29.9 618 (24.9%) 2,208 (26.2%) 982 (29.5%) 18,061 (28.9%) 21,869 (28.5%)
 30-34.9 382 (15.4%) 1,518 (18.0%) 528 (15.9%) 11,373 (18.2%) 13,801 (18.0%)
 35-39.9 210 (8.5%) 891 (10.6%) 236 (7.1%) 5,289 (8.5%) 6,626 (8.6%)
 40+ 193 (7.8%) 839 (10.0%) 143 (4.3%) 3,599 (5.8%) 4,774 (6.2%)
 Unknown 593 (23.9%) 1,110 (13.2%) 440 (13.2%) 10,106 (16.2%) 12,249 (16.0%)
Average DBP within 1 y before index date
 Mean (SD) 65.2 (9.44) 64.8 (9.41) 64.5 (9.76) 68.6 (9.44) 67.9 (9.56)
 < 60 524 (21.1%) 2,218 (26.3%) 963 (28.9%) 8,474 (13.6%) 12,179 (15.9%)
 60 to < 80 1,306 (52.6%) 4,779 (56.7%) 1,764 (53.0%) 38,829 (62.2%) 46,678 (60.9%)
 80+ 129 (5.2%) 472 (5.6%) 208 (6.3%) 6,441 (10.3%) 7,250 (9.5%)
 Unknown 526 (21.2%) 967 (11.5%) 393 (11.8%) 8,695 (13.9%) 10,581 (13.8%)
Average SBP within 1 y before index date
 Mean (SD) 126.1 (15.85) 1,26.9 (14.71) 118.0 (15.66) 129.5 (13.39) 128.6 (13.96)
 < 120 659 (26.5%) 2,278 (27.0%) 1,658 (49.8%) 11,052 (17.7%) 15,647 (20.4%)
 120 to < 140 959 (38.6%) 3,926 (46.5%) 1,019 (30.6%) 32,593 (52.2%) 38,497 (50.2%)
 140+ 341 (13.7%) 1,265 (15.0%) 258 (7.8%) 10,099 (16.2%) 11,963 (15.6%)
 Unknown 526 (21.2%) 967 (11.5%) 393 (11.8%) 8,695 (13.9%) 10,581 (13.8%)
CKD stage/eGFR (mL/min/1.73 m2)
 <15 10 (0.4%) 85 (1.0%) 30 (0.9%) 738 (1.2%) 863 (1.1%)
 15-29 252 (10.1%) 850 (10.1%) 311 (9.3%) 5,097 (8.2%) 6,510 (8.5%)
 30-45 2,223 (89.5%) 7,501 (88.9%) 2,987 (89.75%) 56,604 (90.7%) 69,315 (90.4%)
Weighted Charlson comorbidity, median (IQR) 5.0 (4.0, 7.0) 6.0 (4.0, 7.0) 6.0 (5.0, 7.0) 4.0 (2.0, 5.0) 4.0 (2.0, 5.0)
Elixhauser comorbidity, median (IQR) 7.0 (6.0, 9.0) 9.0 (7.0, 11.0) 9.0 (7.0, 11.0) 5.0 (4.0, 7.0) 5.0 (4.0, 8.0)
Pre-existing comorbid conditions, n (%)
 Diabetes 1,320 (53.1%) 4,691 (55.6%) 1,857 (55.8%) 27,510 (44.1%) 35,378 (46.1%)
 Hypertension 2,110 (84.9%) 7,743 (91.8%) 2,992 (89.9%) 47,725 (76.4%) 60,570 (79.0%)
 Atrial fibrillation 583 (23.5%) 3,035 (36.0%) 1,245 (37.4%) 3,511 (5.6%) 8,374 (10.9%)
 Coronary artery disease 1,252 (50.4%) 3,875 (45.9%) 2,066 (62.1%) 10,022 (16.1%) 17,215 (22.4%)
 Malignancy 281 (11.3%) 1048 (12.4%) 418 (12.6%) 7524 (12.1%) 9271 (12.1%)

Abbreviations: BMI, body mass index; CKD, chronic kidney disease; DBP, diastolic blood pressure; EF, ejection fraction; eGFR, estimated glomerular filtration rate; body mass index; HF, heart failure; IQR, interquartile range; SBP, systolic blood pressure; SD, standard deviation.